According to a new report published by Introspective Market Research, Eubiotics Market by Type, Form, Livestock, and Function, The Global Eubiotics Market Size Was Valued at USD 5.95 Billion in 2024 and is Projected to Reach USD 11.77 Billion by 2032, Growing at a CAGR of 8.9%.

Introduction / Market Overview:
The global eubiotics market is a vital and rapidly growing segment within the animal nutrition industry, focused on products that enhance gut health and overall well-being in livestock. Eubiotics, which include probiotics, prebiotics, essential oils, and organic acids, are defined as feed additives that promote a balanced intestinal microbiota. Their primary advantage over traditional antibiotic growth promoters (AGPs), which are increasingly banned or restricted worldwide, lies in providing a safe, sustainable, and effective alternative for improving animal performance and health. By supporting a beneficial gut microbiome, eubiotics enhance nutrient absorption, strengthen the immune system, and improve feed efficiency.

This natural approach to animal husbandry directly leads to healthier livestock, improved growth rates, and higher-quality meat, milk, and eggs. The main applications of eubiotics span all major livestock sectors, playing a crucial role in modern production systems. They are essential in poultry, swine, ruminant (cattle, sheep), and aquaculture industries, where they are used to mitigate the impact of production stress, prevent enteric diseases, and maintain optimal gut function. Their adoption is a cornerstone of sustainable and profitable animal production in the post-antibiotic era.

Market Segmentation:
The Eubiotics Market is segmented into Type, Form, Livestock, and Function. By Type, the market is categorized into Probiotics, Prebiotics, Organic Acids, and Essential Oils. By Form, the market is categorized into Solid/Dry and Liquid. By Livestock, the market is categorized into Poultry, Swine, Ruminants, Aquaculture, and Others. By Function, the market is categorized into Nutrition & Gut Health, Yield Enhancement, and Immunity & Disease Prevention.

Growth Driver:
The single most powerful driver for the eubiotics market is the stringent and expanding global regulatory ban on the use of antibiotic growth promoters (AGPs) in animal feed. Mounting concerns over antimicrobial resistance (AMR) have prompted governments worldwide, particularly in Europe, North America, and key Asian markets, to prohibit the non-therapeutic use of antibiotics. This regulatory shift has created an urgent and massive void in animal nutrition that eubiotics are uniquely positioned to fill. Livestock producers are compelled to seek safe, effective, and approved alternatives to maintain animal health, welfare, and productivity. This non-discretionary transition from AGPs to eubiotic solutions is fueling sustained, high-volume demand across all major livestock segments.

Market Opportunity:
A significant market opportunity lies in the development and commercialization of advanced, synergistic eubiotic blends and precision delivery systems. While single-ingredient products are common, the future lies in scientifically formulated combinations—such as probiotics with specific prebiotics (synbiotics) or organic acids with essential oils—that deliver enhanced, multi-faceted benefits for gut health, immunity, and performance. Furthermore, innovation in encapsulation and micro-encapsulation technologies to protect sensitive ingredients like probiotics from gastric acids and high-temperature feed processing presents a major growth avenue. Companies that invest in R&D to create these next-generation, stable, and highly effective targeted solutions can capture premium market value and build long-term partnerships with feed manufacturers.

Eubiotics Market, Segmentation
The Eubiotics Market is segmented on the basis of Type, Form, Livestock, and Function.

Type
The Type segment is further classified into Probiotics, Prebiotics, Organic Acids, and Essential Oils. Among these, the Probiotics sub-segment accounted for the highest market share in 2024. Probiotics, comprising live beneficial bacteria like Lactobacillus and Bifidobacterium strains, dominate the market due to their direct and well-established role in colonizing the gut and competitively excluding harmful pathogens. They are the most direct replacement for AGPs, offering proven benefits in improving feed conversion ratio (FCR), enhancing digestion, and boosting immunity. Their extensive research backing and high consumer and producer acceptance solidify their leading position.

Livestock
The Livestock segment is further classified into Poultry, Swine, Ruminants, Aquaculture, and Others. Among these, the Poultry sub-segment accounted for the highest market share in 2024. The global poultry industry, being the largest and most intensively farmed livestock sector, is the primary consumer of eubiotics. Broilers and layers are highly susceptible to gut health challenges that impact growth, feed efficiency, and egg production. The high density of production and the economic sensitivity to performance metrics make the adoption of eubiotics a critical strategy for profitability, driving the largest volume demand in this segment.

Some of The Leading/Active Market Players Are-
• Koninklijke DSM N.V. (Netherlands)
• Cargill, Incorporated (US)
• BASF SE (Germany)
• Novus International, Inc. (US)
• Chr. Hansen Holding A/S (Denmark)
• Kemin Industries, Inc. (US)
• Lallemand Inc. (Canada)
• Lesaffre (France)
• Calpis Co., Ltd. (Japan)
• Novozymes A/S (Denmark)
• ADDCON GmbH (Germany)
• Bluestar Adisseo Co., Ltd. (China)
• Evonik Industries AG (Germany)
• Alltech, Inc. (US)
• “and other active players.”

Key Industry Developments
News 1:
In March 2024, Chr. Hansen launched a new, patented probiotic strain specifically developed to enhance gut barrier function and immune response in poultry.
This targeted innovation addresses key challenges in antibiotic-free production, helping producers manage enteric diseases and reduce mortality rates without pharmaceuticals.

News 2:
In January 2024, Cargill announced a strategic investment to expand its production capacity for precision-release organic acid blends in Asia-Pacific.
The expansion aims to meet soaring regional demand for acidifiers that effectively control pathogens in swine and poultry feed, supporting the region's transition away from AGPs.

Key Findings of the Study
• Probiotics led the market by type, and the Poultry sector was the largest livestock segment in 2024.
• Europe is the leading regional market, driven by early and strict bans on AGPs and high animal welfare standards.
• Global bans on antibiotic growth promoters (AGPs) are the primary driver for market expansion.
• Key trends include the rise of synbiotic blends, precision nutrition, and advanced encapsulation technologies for enhanced efficacy.